Answers are grounded in this paper and cite their sources.
Targeting NKG2A to elucidate natural killer cell ontogenesis and to develop novel immune-therapeutic strategies in cancer therapy,
No takes yet. Share an insight, caveat, or question.
Vivier et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: